Similar Jobs
See allAssociate Director / Director, Medical Science Liaison – Women’s Health
Overview
US
Medical Affairs
Communication
Presentation
Medical Science Liaison, Southeast US
Mirum Pharmaceuticals
US
Communication
MS Office
Organizational
Associate Director, Thought Leader Strategy, I/O Commercial Franchise
Coherus
US
Marketing
Strategic Thinking
Project Management
ION® Endoluminal Territory Associate (m/w/d)
Intuitive
Europe
Sales
Clinical
Training
Sr. Director, Clinical Scientist
Kyverna Therapeutics
US
GCP
Regulatory Affairs
Role Overview & Key Functions:
- Serve as Karyopharm’s field-based scientific expert supporting the endometrial cancer program and broader solid tumor strategy.
- Build relationships with gynecologic oncologists, medical oncologists, investigators, academic centers, and community oncology practices.
- Facilitate the compliant exchange of scientific information and gather meaningful insights for development and launch planning.
Candidate Profile & Requirements:
- Advanced doctoral degree preferred (PharmD, MD, DO, PhD); candidates with significant oncology MSL experience considered.
- 3+ years of oncology MSL experience required; solid tumor experience required.
- Strong scientific communication and presentation skills; ability to travel up to 75%.
Our Value Proposition:
- Pioneering nuclear export inhibition to develop differentiated therapies for cancer patients.
- Building upon an established commercial foundation in multiple myeloma while advancing selinexor across additional cancers.
- Opportunity to help shape what comes next in a collaborative, fast-moving environment where individual contributions are visible and valued.
Karyopharm Therapeutics
Karyopharm Therapeutics is pioneering the science of nuclear export inhibition to develop differentiated therapies for cancer patients. The company has an established commercial foundation in multiple myeloma and is advancing selinexor across hematologic and solid tumors, with a collaborative, fast-moving environment where individual contributions are valued.